FindMyKOL

Joshua Samuels, MD

Basic profile

Memorial Hermann

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionHouston, TX · South CentralSpecialtyPediatric NephrologyFocusNephrology
Active KOLFindMyKOL type: RegionalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH funding2006–2010

Joshua Samuels is a Nephrology physician affiliated with Memorial Hermann. OpenAlex indexes 154 publications with 9,532 citations (h-index 42). By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Nephrology profiles in the FindMyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
154publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

9,532citations

Citations across these publications.

42h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2006–2010

Federally funded research awards.

View funding ↓

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Apellis Pharmaceuticals, Inc.
    Program year20251 payment
    $126
  • Novartis Pharmaceuticals Corporation
    Program year20251 payment
    $99
  • Novo Nordisk Inc
    Program year20251 payment
    $34
All 9 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    67.6%
    Kinase inhibitor67.6%
    Everolimus73%Afinitor27%
    Part D<11 patients
  • Cardiovascular

    32.4%
    ACE inhibitor15.5%
    Lisinopril100%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)9.5%
    Losartan Potassium100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 2006–2010 per NIH RePORTER. The latest:

All 5 award records: search, sort and filter.Explore →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”